雄激素和雌激素以及催乳素性相关激素受体在喉鳞状细胞癌中的表达及预后影响

费梦嘉; 徐雅男; 王家东

doi:10.13201/j.issn.1001-1781.2018.03.008

雄激素和雌激素以及催乳素性相关激素受体在喉鳞状细胞癌中的表达及预后影响

- 上海交通大学医学院附属仁济医院头颈外科(上海, 200001)
基金项目:
上海高校选拔培养优秀青年教师科研专项基金（No：101005.001.14.115）

详细信息

通讯作者: 王家东,E-mail:drjiadongw@aliyun.com

中图分类号: R739.65

收稿日期: 2017-09-18

The expression and clinical progression of androgen, estrogen and prolactin receptor in laryngeal squamous cell carcinoma

- 1. Department of Head and Neck Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200001, China

More Information

Corresponding author: WANG Jiadong, E-mail: drjiadongw@aliyun.com

Received Date: 18 September 2017

摘要

摘要: 目的：探讨在喉鳞状细胞癌（LSCC）中，包括雄激素受体（AR）和雌激素受体（ER）在内的性激素受体，其表达情况和作用的异同以及机制。结合催乳素受体（PRLR）的表达情况，共同分析3个受体对于肿瘤的预后影响。方法：本研究针对112例LSCC患者（男95例、女17例）的肿瘤组织及邻近的正常组织进行免疫组织化学和逆转录聚合酶链反应（RT-PC）分析。结果：在肿瘤组织中的AR，ER-α以及PRLR的表达，其在蛋白水平和mRNA水平均远高于邻近的正常组织（P>0.05）。在以免疫组织化学结果为基础的进一步分析中发现：肿瘤组织中ER-α（P=0.06）以及PRLR（P=0.02）的相对高表达预示着LSCC患者术后生存率不高。此外，ER-α的高表达和PRLR的高表达比较差异有统计学意义（r=0.802，P=0.04），表明LSCC各激素受体表达可能存在相互影响。通过对组织样本的研究，发现激素受体表达与临床肿瘤病变情况和总体生存数据有密切关系。结论：性相关激素受体表达情况对LSCC的发生发展有其特定的影响。
- 喉肿瘤 /
- 雄激素受体 /
- 雌激素受体-ɑ /
- 催乳素受体 /
- 总体生存率
Abstract: Objective: The aim of this study is to analyze the different expression and function of androgen receptors (AR) and estrogen receptor (ER-α) in laryngeal squamous cell carcinoma (LSCC). In combination with the expression of prolactin receptor (PRLR), we analyzed the prognostic impact of three receptors on the laryngeal carcinoma.Method: In this study, immunohistochemistry and reverse transcription polymerase chain reaction (RT-PC) analysis were performed on the tumor tissues and adjacent normal tissues in 112 LSCC patients (95 males and 17 females). We found that hormone receptor expression is closely related to the clinical tumor lesions and overall survival data.Result: The expression of AR, ER-α and PRLR in tumor tissues were much higher than those in adjacent normal tissues (P>0.05) at both protein and mRNA levels. The higher PRLR level indicate poor survival in LSCC patients (P=0.02), while higher ER-α expression could influence the survival with considerable trend toward significance (P=0.06). Furthermore, the higher expression of ER-α in tumours were corresponding with PRLR cytoplasmic higher level expression (r=0.802, P=0.04). This mutual promoted effect between ER-α and PRLR possibly suggests potential mechanisms among those sex related hormone receptors in laryngeal cancer.Conclusion: It has become increasingly credible that the sex related hormone receptors play an important role in the development of LSCC.
- laryngeal neoplasms /
- androgen receptor /
- estrogen receptor alpha /
- prolactin receptor /
- overall survival

HTML全文

参考文献(14)

[1]	SIEGEL R L, MILLER K D, JEMAL A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66:7-30.
[2]	LUKITS J, REMENAR E, RASO E, et al.Molecular identification, expression and prognostic role of estrogen-and progesterone receptors in head and neck cancer[J].Int J Oncol, 2007, 30:155-160.
[3]	BIANCHINI C, PASTORE A, PELUCCHI S, et al.Sex hormone receptor levels in laryngeal carcinoma:a comparison between protein and RNA evaluations[J].Eur Arch Otorhinolaryngol, 2008, 265:1089-1094.
[4]	BAUERNHOFER T, PICHLER M, WIECKOWSKI E, et al.Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck[J].Br J Cancer, 2011, 104:1641-1648.
[5]	LOPEZ-PULIDO E I, MUNOZ-VALLE J F, DEL TORO-ARREOLA S, et al.High expression of prolactin receptor is associated with cell survival in cervical cancer cells[J].Cancer Cell Int, 2013, 13:103-103.
[6]	LANGEVIN S M, GRANDIS J R, TAIOLI E.Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk[J].Cancer Lett, 2011, 310:216-221.
[7]	MISONO S, MARMOR S, YUEH B, et al.Treatment and survival in 10, 429patients with localized laryngeal cancer:apopulation-based analysis[J].Cancer, 2014, 120:1810-1817.
[8]	SCHMITTGEN T D, LIVAK K J.Analyzing realtime PCR data by the comparative C (T) method[J].Nat Protoc, 2008, 3:1101-1108.
[9]	DOLL C, ARSENIC R, LAGE H, et al.Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade[J].Anticancer Res, 2015, 35:5867-5872.
[10]	WU T F, LUO F J, CHANG Y L, et al.The oncogenic role of androgen receptors in promoting the growth of oral squamous cell carcinoma cells[J].Oral Dis, 2015, 21:320-327.
[11]	COLELLA G, IZZO G, CARINCI F, et al.Expression of sexual hormones receptors in oral squamous cell carcinoma[J].Int J Immunopathol Pharmacol, 2011, 24(2Suppl):129-132.
[12]	GALBAUGH T, FEENEY Y B, CLEVENGER C V.Prolactin receptor-integrin cross-talk mediated by SIRPalpha in breast cancer cells[J].Mol Cancer Res, 2010, 8:1413-1424.
[13]	DE CASTRO G Jr, PASINI F S, SIQUEIRA S A, et al.ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgeryand adjuvant cisplatin-basedchemoradiation[J].Oncol Rep, 2011, 25:693-699.
[14]	HARBAUM L, POLLHEIMER M J, BAUERNHOFER T, et al.Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases[J].Mod Pathol, 2010, 23:961-971.